12.23.11 DxNA, LLC., completes the move to a new facility with the certification of a new Class 7 clean room, which allows for significant future expansion of DxNA's cartridge manufacturing capacity.
11.10.11 DxNA, LLC., is notified that it has met the requirements of the In-vitro Diagnostics Directive 98/79/EC (CE mark) for the GeneSTAT® Analyzer
10.26.11 DxNA,LLC. and the Chinese National Institute for Virus Disease Control and Prevention enter into a contract to develop and validate the GeneSTAT® and test cartridges for FluA/B surveillance in China.
9.29.11 DxNA,LLC., and Dr. Duane Gubler of Duke University-NUS Singapore enter into an agreement to validate the GeneSTAT© system for the detection of various tropical diseases. Systems will initially be placed in Sri Lanka and later into other countries of southeast Asia.
5.24.11 United States Patent Office Issues Patent for DxNA's GeneSTAT® System: Rapid Thermocycler With Moveable Cooling Assembly." USPTO No. 7,939,312